Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer

By Martin M.   Romero A.   Cheang M.   López García-Asenjo J.   García-Saenz J.   Oliva B.   Román J.   He X.   Casado A.   Torre J.   Furio V.   Puente J.   Caldés T.   Vidart J.   Lopez-Tarruella Sara   Diaz-Rubio E.   Perou C.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 127-136

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of response to second-line endocrine therapy for breast cancer

By Cheung K.L.   Willsher P.C.   Pinder S.E.   Ellis I.O.   Elston C.W.   Nicholson R.I.   Blamey R.W.   Robertson a.J.F.R.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 3, 1997-09 ,pp. : 219-224

Springer Publishing Company

Access to resources Recommend Favorite

Clinical evaluation of chemotherapy response predictors developed from breast cancer cell lines

By Liedtke Cornelia  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 301-309

Springer Publishing Company

Access to resources Recommend Favorite

The role of biological markers as predictors of response to preoperative chemotherapy in large primary breast cancer

By Cocquyt Veronique   Schelfhout Vera   Blondeel Phillip   Depypere Herman   Daems Kristof   Serreyn Rudolphe   Praet Marleen   Beele Simon  

Medical Oncology, Vol. 20, Iss. 3, 2003-09 ,pp. : 221-231

Humana Press, Inc

Access to resources Recommend Favorite

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

By Fernández-Sánchez Mónica   Gamboa-Dominguez Armando   Uribe Norma   García-Ulloa Ana   Flores-Estrada Diana   Candelaria Myrna   Arrieta Oscar  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 171-183

Humana Press, Inc

Access to resources Recommend Favorite